Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ

Revenue (LTM)

$829M

+23258.2% YoY

Net Income (LTM)

$-2M

+99.7% YoY

Free Cash Flow

$157M

Revenue CAGR (5Y)

+56.6%

—Marginsstable

FCFTurned positive

Unprofitable

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Revenue	138	243↑75.9%	241↓1.0%	4↓98.5%	829↑23258.2%
Gross Profit	138	243↑75.9%	241↓1.0%	4↓98.5%	806↑22584.3%
Operating Income	-149	-179↓19.8%	-205↓14.8%	-601↓193.2%	98↑116.4%
Net Income	-141	-176↓25.0%	-205↓16.6%	-599↓192.0%	-2↑99.7%
EBITDA	-133	-162↓22.4%	-176↓8.2%	-562↓219.6%	165↑129.4%
EPS Diluted	-1.36	-1.67↓22.8%	-1.92↓15.0%	-5.00↓160.4%	-0.01↑99.8%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Cash & Equivalents	184	108↓41.4%	111↑2.7%	103↓7.4%	227↑120.6%
Total Current Assets	385	405↑5.4%	420↑3.5%	695↑65.8%	951↑36.7%
Total Assets	710	692↓2.6%	766↑10.6%	1,140↑48.9%	1,385↑21.5%
Total Current Liabilities	147	139↓5.2%	105↓24.1%	103↓2.2%	195↑89.5%
Total Liabilities	301	274↓9.2%	478↑74.9%	949↑98.3%	882↓7.0%
Total Equity	409	399↓2.5%	271↓31.9%	185↓31.7%	466↑151.3%
Total Debt	26	82↑219.3%	383↑370.1%	852↑122.1%	366↓57.0%
Net Debt	-159	-26↑83.4%	273↑1131.5%	749↑174.8%	140↓81.3%

Metric	Sep 21	Sep 22	Sep 23	Sep 24	Sep 25
Operating Cash Flow	171	-136↓179.5%	-154↓13.0%	-463↓200.8%	180↑138.8%
Capital Expenditure	-24	-53↓123.9%	-177↓234.9%	-141↑20.0%	-23↑84.0%
Free Cash Flow	148	-189↓227.9%	-331↓75.0%	-604↓82.8%	157↑126.0%
Stock-Based Comp	77	121↑57.7%	78↓35.4%	74↓5.3%	63↓14.3%
Net Change in Cash	41	-76↓287.1%	3↑103.8%	-8↓384.3%	124↑1609.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance